The epidemiology of ALS: a conspiracy of genes, environment and time

[1]  O. Hardiman,et al.  Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: A population‐based case–control cohort study of familial and sporadic amyotrophic lateral sclerosis , 2013, Annals of neurology.

[2]  O. Hardiman,et al.  Age at onset of amyotrophic lateral sclerosis is proportional to life expectancy , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[3]  R. Holman,et al.  Amyotrophic lateral sclerosis/motor neuron disease deaths in the United States, 1999–2009 , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[4]  D. Morris,et al.  Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing , 2013, Journal of Medical Genetics.

[5]  O. Hardiman,et al.  Cognitive changes predict functional decline in ALS , 2013, Neurology.

[6]  R. Holman,et al.  Incidence of amyotrophic lateral sclerosis among American Indians and Alaska natives. , 2013, JAMA neurology.

[7]  L. Goldstein,et al.  Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment , 2013, The Lancet Neurology.

[8]  C. Ki,et al.  Analysis of the C9orf72 hexanucleotide repeat expansion in Korean patients with familial and sporadic amyotrophic lateral sclerosis , 2013, Neurobiology of Aging.

[9]  M. Thun,et al.  Premorbid body mass index and risk of amyotrophic lateral sclerosis , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[10]  F. Clavel-Chapelon,et al.  Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis , 2013, Neurology.

[11]  L. H. van den Berg,et al.  Lifetime physical activity and the risk of amyotrophic lateral sclerosis , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[12]  A. Chiò,et al.  Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995–2009 , 2013, Journal of Neurology.

[13]  J. Clarimón,et al.  Analysis of the C9orf72 Gene in Patients with Amyotrophic Lateral Sclerosis in Spain and Different Populations Worldwide , 2013, Human mutation.

[14]  A. Chiò,et al.  Amyotrophic lateral sclerosis in Piedmont (Italy): A Bayesian spatial analysis of the incident cases , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[15]  Rosa Rademakers,et al.  How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders? , 2012, Current opinion in neurology.

[16]  Chi-shin Hwang,et al.  Riluzole and Prognostic Factors in Amyotrophic Lateral Sclerosis Long-term and Short-term Survival: A Population-Based Study of 1149 Cases in Taiwan , 2012, Journal of epidemiology.

[17]  M. Benatar,et al.  Utility of Capture-Recapture Methodology to Assess Completeness of Amyotrophic Lateral Sclerosis Case Ascertainment , 2012, Neuroepidemiology.

[18]  Hitoshi Takahashi,et al.  Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72 , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[19]  P. Tsai,et al.  A hexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan , 2012, Neurobiology of Aging.

[20]  S. Tsuji,et al.  C9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of Japan. , 2012, Archives of neurology.

[21]  Olubunmi Abel,et al.  ALSoD: A user‐friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics , 2012, Human mutation.

[22]  L. H. van den Berg,et al.  Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study. , 2012, American journal of epidemiology.

[23]  Michelle K. Lupton,et al.  The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder , 2012, European Journal of Human Genetics.

[24]  A. Al-Chalabi,et al.  Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study , 2012, The Lancet Neurology.

[25]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[26]  A. Al-Chalabi,et al.  A proposed staging system for amyotrophic lateral sclerosis , 2012, Brain : a journal of neurology.

[27]  T. Hortobágyi,et al.  p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS , 2011, Acta Neuropathologica.

[28]  M. Druet‐Cabanac,et al.  Contribution of geolocalisation to neuroepidemiological studies: Incidence of ALS and environmental factors in Limousin, France , 2011, Journal of the Neurological Sciences.

[29]  Ammar Al-Chalabi,et al.  Clinical genetics of amyotrophic lateral sclerosis: what do we really know? , 2011, Nature Reviews Neurology.

[30]  A. Al-Chalabi,et al.  The risk to relatives of patients with sporadic amyotrophic lateral sclerosis , 2011, Brain : a journal of neurology.

[31]  C. Lewis,et al.  Modelling the Effects of Penetrance and Family Size on Rates of Sporadic and Familial Disease , 2011, Human Heredity.

[32]  O. Hardiman,et al.  The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[33]  Leonard H van den Berg,et al.  Population based epidemiology of amyotrophic lateral sclerosis using capture–recapture methodology , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[34]  Janel O. Johnson,et al.  Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene. , 2011, Archives of neurology.

[35]  M. P. de la Paz,et al.  Increase in motor neuron disease mortality in Spain: Temporal and geographical analysis (1990–2005) , 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[36]  O. Hardiman,et al.  Proposed criteria for familial amyotrophic lateral sclerosis , 2011, Amyotrophic Lateral Sclerosis.

[37]  L. H. van den Berg,et al.  Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[38]  M. Thun,et al.  Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts. , 2011, Archives of neurology.

[39]  A. Al-Chalabi,et al.  Low index-to-ring finger length ratio in sporadic ALS supports prenatally defined motor neuronal vulnerability , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[40]  T. Tango,et al.  Temporal trends and geographic clusters of mortality from amyotrophic lateral sclerosis in Japan, 1995–2004 , 2010, Journal of the Neurological Sciences.

[41]  O. Hardiman,et al.  Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[42]  R. Bidigare,et al.  Prominent Human Health Impacts from Several Marine Microbes: History, Ecology, and Public Health Implications , 2010, International journal of microbiology.

[43]  R. Howard,et al.  Metastatic choriocarcinoma , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[44]  A. Al-Chalabi,et al.  An estimate of amyotrophic lateral sclerosis heritability using twin data , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[45]  L. Goldstein,et al.  The sex ratio in amyotrophic lateral sclerosis: A population based study , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[46]  U. Ekelund,et al.  Validation of the historical adulthood physical activity questionnaire (HAPAQ) against objective measurements of physical activity , 2010, The international journal of behavioral nutrition and physical activity.

[47]  A Al-Chalabi,et al.  Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[48]  O. Hardiman,et al.  The epidemiology of motor neuron disease in Northern Ireland using capture-recapture methodology , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[49]  R. Pamphlett.  STUDY OF 962 PATIENTS INDICATES PROGRESSIVE MUSCULAR ATROPHY IS A FORM OF ALS , 2010, Neurology.

[50]  J. Feussner,et al.  Neurological mortality among Gulf War veterans. , 2010, American journal of industrial medicine.

[51]  M. Hernán,et al.  Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study , 2010, BMC neurology.

[52]  鮫島 浩,et al.  Population-based study からみた神経予後不良因子の検討 , 2009 .

[53]  C. Armon.  Smoking may be considered an established risk factor for sporadic ALS , 2009, Neurology.

[54]  Daniel Stahl,et al.  Latent Cluster Analysis of ALS Phenotypes Identifies Prognostically Differing Groups , 2009, PloS one.

[55]  Han K. Kang,et al.  Neurological mortality among U.S. veterans of the Persian Gulf War: 13-year follow-up. , 2009, American journal of industrial medicine.

[56]  E. Beghi,et al.  Incidence of amyotrophic lateral sclerosis in Europe , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[57]  L. H. van den Berg,et al.  A long-term prospective study of the natural course of sporadic adult-onset lower motor neuron syndromes. , 2009, Archives of neurology.

[58]  G. Logroscino,et al.  Reduced frequency of ALS in an ethnically mixed population , 2009, Neurology.

[59]  A. Al-Chalabi,et al.  Natural history and clinical features of the flail arm and flail leg ALS variants , 2009, Neurology.

[60]  Xun Hu,et al.  Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.

[61]  J L Haines,et al.  Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .

[62]  P. Preux,et al.  Prognosis of ALS: Comparing data from the Limousin referral centre, France, and a Uruguayan population , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[63]  D. Mash,et al.  Beyond Guam: The cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[64]  L. H. van den Berg,et al.  What we truly know about occupation as a risk factor for ALS: A critical and systematic review , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[65]  O. Hardiman,et al.  An all‐Ireland epidemiological study of MND, 2004–2005 , 2009, European journal of neurology.

[66]  L. H. van den Berg,et al.  Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: A systematic review , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[67]  E. Beghi,et al.  Prognostic factors in ALS: A critical review , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[68]  A. Al-Chalabi,et al.  Geographical Clustering of Amyotrophic Lateral Sclerosis in South-East England: A Population Study , 2008, Neuroepidemiology.

[69]  K. Thennarasu,et al.  Clinical characteristics and survival pattern of 1153 patients with amyotrophic lateral sclerosis: Experience over 30 years from India , 2008, Journal of the Neurological Sciences.

[70]  C. Armon.  Sports and trauma in amyotrophic lateral sclerosis revisited , 2007, Journal of the Neurological Sciences.

[71]  Hiroyuki Nodera,et al.  [New diagnostic criteria of ALS (Awaji criteria)]. , 2007, Brain and nerve = Shinkei kenkyu no shinpo.

[72]  P. Comba,et al.  Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data , 2007, European Journal of Epidemiology.

[73]  J. Alappat.  ETHNIC VARIATION IN THE INCIDENCE OF ALS: A SYSTEMATIC REVIEW , 2007, Neurology.

[74]  P. Gordon,et al.  Lou Gehrig, Rawhide, and 1938 , 2007, Neurology.

[75]  A. Al-Chalabi,et al.  Three soccer playing friends with simultaneous amyotrophic lateral sclerosis , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[76]  T. Hortobágyi,et al.  Electrical injury and amyotrophic lateral sclerosis: a systematic review of the literature , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[77]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[78]  H. Mitsumoto,et al.  The natural history of primary lateral sclerosis , 2006, Neurology.

[79]  S. Grambow,et al.  Estimating the Occurrence of Amyotrophic Lateral Sclerosis among Gulf War (1990–1991) Veterans Using Capture-Recapture Methods , 2005, Neuroepidemiology.

[80]  A. Chiò,et al.  Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. , 2005, Brain : a journal of neurology.

[81]  M. Thun,et al.  Prospective study of military service and mortality from ALS , 2005, Neurology.

[82]  S. Ho,et al.  An epidemiological study of motor neuron disease in Hong Kong , 2005, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[83]  M. Thun,et al.  Prospective study of cigarette smoking and amyotrophic lateral sclerosis. , 2004, American journal of epidemiology.

[84]  Paul Alan Cox,et al.  Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[85]  E. Beghi,et al.  The sinister side of Italian soccer , 2003, The Lancet Neurology.

[86]  S. Grambow,et al.  Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations , 2003, Neurology.

[87]  Paul Alan Cox,et al.  Biomagnification of cycad neurotoxins in flying foxes , 2003, Neurology.

[88]  A C Gatrell,et al.  Spatial clustering of amyotrophic lateral sclerosis in Finland at place of birth and place of death. , 2003, American journal of epidemiology.

[89]  Y. Stern,et al.  Premorbid weight, body mass, and varsity athletics in ALS , 2002, Neurology.

[90]  W. Longstreth,et al.  Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. , 2000, American journal of epidemiology.

[91]  W. Longstreth,et al.  Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. II. Diet. , 2000, American journal of epidemiology.

[92]  J. De Pedro-Cuesta,et al.  Differential features of motor neuron disease mortality in Spain. , 1997, International journal of epidemiology.

[93]  P. Leigh,et al.  Motor neuron disease. , 1994, Springer London.

[94]  B. Brooks,et al.  El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.

[95]  P N Leigh,et al.  The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study. , 1993, Brain : a journal of neurology.

[96]  B. Pant,et al.  Amyotrophic lateral sclerosis (ALS): A phylogenetic disease of the corticomotoneuron? , 1992, Muscle & nerve.

[97]  A. Chiò,et al.  Motor neuron disease in the province of Turin, Italy, 1966–1980 Survival analysis in an unselected population , 1984, Journal of the Neurological Sciences.

[98]  THE AMYOTROPHIC LATERAL SCLEROSIS OF GUAM , 1966, The Medical journal of Australia.

[99]  L. Kurland,et al.  Epidemiologic Investigations of Amyotrophic Lateral Sclerosis , 1955, Neurology.

[100]  Mulder Dw,et al.  Neurologic diseases on the island of Guam. , 1954 .

[101]  L. Kurland,et al.  Epidemiologic Investigations of Amyotrophic Lateral Sclerosis , 1954, Neurology.

[102]  V. Palladino,et al.  Amyotrophic lateral sclerosis; fifty cases observed on Guam. , 1953, The Journal of nervous and mental disease.

[103]  D. R. Koerner.  AMYOTROPHIC LATERAL SCLEROSIS ON GUAM: A CLINICAL STUDY AND REVIEW OF THE LITERATURE , 1952 .

[104]  C. Aring,et al.  A CRITICAL REVIEW , 1939, Journal of neurology and psychiatry.

[105]  J. Snow.  On the Mode of Communication of Cholera , 1856, Edinburgh medical journal.

[106]  Cheng-Li Lin,et al.  A population-based cohort study. , 2015 .

[107]  Emily Hoch,et al.  – a review of the scientific literature , 2013 .

[108]  A. Banerjee,et al.  A 10-year prospective population-based study of the incidence and outcome of acute abdominal aortic aneurysms: implications for screening , 2013 .

[109]  Presumption of service connection for amyotrophic lateral sclerosis. Final rule. , 2009, Federal register.

[110]  W. Bradley,et al.  The ALS/PDC syndrome of Guam and the cycad hypothesis. , 2009, Neurology.

[111]  George Turabelidze,et al.  An epidemiologic investigation of amyotrophic lateral sclerosis in Jefferson County, Missouri, 1998-2002. , 2008, Neurotoxicology.

[112]  A. Al-Chalabi,et al.  Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). , 2007, Neuroepidemiology.

[113]  J. Manson,et al.  Prospective Study of , 2007 .

[114]  A. Al-Chalabi,et al.  Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. , 2006, Journal of neurology.

[115]  S. Gabriel,et al.  Systematic Review of the Literature , 2021, Adherence to Antiretroviral Therapy among Perinatal Women in Guyana.

[116]  Mulder Dw.  Clinical limits of amyotrophic lateral sclerosis. , 1982 .

[117]  L. Kurland,et al.  Neurologic diseases on the island of Guam. , 1954, United States Armed Forces medical journal.

[118]  Jm Charcot,et al.  Deux cas d’atrophie musculaire progressive avec lesions de la substance grise et des faisceaux antero-lateraux de la moelle epiniere , 1869 .